<DOC>
	<DOCNO>NCT00479219</DOCNO>
	<brief_summary>To assess pharmacodynamics ( PD ) biomarkers amyloid beta peptide 40 42 ( Ab40 Ab42 ) CSF , follow single oral dos GSI-953 , investigational drug , healthy young subject patient Alzheimer Disease ( AD ) .</brief_summary>
	<brief_title>Study Evaluating GSI-953 Healthy Young Alzheimer 's Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>For Healthy Young Subjects : Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign 12 lead ECGs . For AD patient : Patients must generally healthy exception Alzheimer Disease . ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>